CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 2, Page 193-196, February 2025.
wiley +1 more source
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan
Bradley S Miller,1 Jo Blair,2 Reiko Horikawa,3 Agnès Linglart,4– 7 Kevin CJ Yuen8 1Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth Fairview Masonic Children’s Hospital, Minneapolis, MN, USA; 2Department of Paediatric ...
Miller BS +4 more
doaj
The efficacy and safety of weekly somatrogon treatment in turkish children with growth hormone deficiency: a real-world cohort study. [PDF]
Gider T +4 more
europepmc +1 more source
Can long-acting growth hormone improve adherence in pediatric growth hormone deficiency? [PDF]
Rodaro C +5 more
europepmc +1 more source
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study. [PDF]
Fleseriu M +17 more
europepmc +1 more source
Long-acting growth hormone for pediatric GHD: insights into molecular modification and clinical application. [PDF]
Gu J, Qiao Y, Gong P.
europepmc +1 more source
Patient and Caregiver Preferences for Once-Weekly Injection Devices for the Treatment of Growth Hormone Deficiency. [PDF]
Chen JV +6 more
europepmc +1 more source
Comparative Efficacy of Once-Weekly Somatrogon Versus Daily Growth Hormone Therapy in Children With Idiopathic Growth Hormone Deficiency: A Real-World Retrospective Study From Greece. [PDF]
Katsoudas S +6 more
europepmc +1 more source

